Hyperbaric oxygen therapy shows promise as a treatment for Alzheimer’s disease
February 29, 2024 • faculty, P&N, Research, students
New findings by a team of researchers at The University of North Texas Health Science Center at Fort Worth’s College of Biomedical and Translational Sciences are expanding our understanding of the potential benefits of hyperbaric oxygen therapy as a treatment for Alzheimer’s disease.
Their study, titled “Hyperbaric Oxygen Alleviates Selective Domains of Cognitive and Motor Deficits in Female 5XFAD Mice,” was published recently in GeroScience, a leading international journal focused on the biology of aging and the pathophysiology of age-related diseases.
“What we see in our research is that hyperbaric oxygen therapy leads to cognitive improvements in Alzheimer’s disease mouse models and that these improvements were more pronounced in females than in males,” said Paapa Mensah-Kane, PhD candidate in the lab of Dr. Nathalie Sumien and first author of the study.
“We are very excited about the results.”
Social media